Drug profile · INN
clomipramine hydrochloride
CLOMIPRAMINE HYDROCHLORIDE
clomipramine hydrochloride (CLOMIPRAMINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — clomipramine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
clomipramine hydrochloride (CLOMIPRAMINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent serotonin transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is clomipramine hydrochloride?
clomipramine hydrochloride (CLOMIPRAMINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for clomipramine hydrochloride?
CLOMIPRAMINE HYDROCHLORIDE is a marketed brand name for clomipramine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clomipramine hydrochloride?
clomipramine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.